tiprankstipranks
Trending News
More News >
China NT Pharma Group Co., Ltd. (HK:1011)
:1011
Hong Kong Market

China NT Pharma Group Co., Ltd. (1011) Stock Statistics & Valuation Metrics

Compare
1 Followers

Total Valuation

China NT Pharma Group Co., Ltd. has a market cap or net worth of HK$252.84M. The enterprise value is HK$469.36M.
Market CapHK$252.84M
Enterprise ValueHK$469.36M

Share Statistics

China NT Pharma Group Co., Ltd. has 674,246,030 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding674,246,030
Owned by Insiders
Owned by Institutions

Financial Efficiency

China NT Pharma Group Co., Ltd.’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.
Return on Equity (ROE)
Return on Assets (ROA)
Return on Invested Capital (ROIC)
Return on Capital Employed (ROCE)
Revenue Per Employee334.82K
Profits Per Employee-5.75M
Employee Count22
Asset Turnover
Inventory Turnover

Valuation Ratios

The current PE Ratio of China NT Pharma Group Co., Ltd. is ―. China NT Pharma Group Co., Ltd.’s PEG ratio is ―.
PE Ratio
PS Ratio
PB Ratio
Price to Fair Value
Price to FCF
Price to Operating Cash Flow
PEG Ratio

Income Statement

In the last 12 months, China NT Pharma Group Co., Ltd. had revenue of 7.37M and earned -143.59M in profits. Earnings per share was -0.04.
Revenue7.37M
Gross Profit7.37M
Operating Income0.00
Pretax Income-33.37M
Net Income-143.59M
EBITDA1.33M
Earnings Per Share (EPS)-0.04

Cash Flow

In the last 12 months, operating cash flow was -5.74M and capital expenditures -131.00K, giving a free cash flow of -5.87M billion.
Operating Cash Flow-5.74M
Free Cash Flow-5.87M
Free Cash Flow per Share>-0.01

Dividends & Yields

China NT Pharma Group Co., Ltd. pays an annual dividend of HK$0.35, resulting in a dividend yield of ―
Dividend Per ShareHK$0.35
Dividend Yield
Payout RatioN/A
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta1.00
52-Week Price Change44.00%
50-Day Moving Average0.23
200-Day Moving Average0.28
Relative Strength Index (RSI)73.71
Average Volume (3m)439.15K

Important Dates

China NT Pharma Group Co., Ltd. upcoming earnings date is Aug 27, 2025, TBA Not Confirmed.
Last Earnings DateMar 31, 2025
Next Earnings DateAug 27, 2025
Ex-Dividend DateJul 10, 2018

Financial Position

China NT Pharma Group Co., Ltd. as a current ratio of ―, with Debt / Equity ratio of ―
Current Ratio
Quick Ratio
Debt to Market Cap
Net Debt to EBITDA
Interest Coverage Ratio

Taxes

In the past 12 months, China NT Pharma Group Co., Ltd. has paid 122.00K in taxes.
Income Tax122.00K
Effective Tax Rate

Enterprise Valuation

China NT Pharma Group Co., Ltd. EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.
EV to Sales
EV to EBITDA
EV to Free Cash Flow
EV to Operating Cash Flow

Balance Sheet

China NT Pharma Group Co., Ltd. has HK$8.92M in cash and marketable securities with ¥1.01B in debt, giving a net cash position of HK$347.67M billion.
Cash & Marketable SecuritiesHK$8.92M
Total Debt¥1.01B
Net CashHK$347.67M
Net Cash Per ShareHK$0.52
Tangible Book Value Per Share

Margins

Gross margin is ―, with operating margin of ―, and net profit margin of ―.
Gross Margin
Operating Margin
Pretax Margin
Net Profit Margin
EBITDA Margin
EBIT Margin

Analyst Forecast

The average price target for China NT Pharma Group Co., Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target
Price Target Upside
Analyst Consensus
Analyst Count0
Revenue Growth Forecast
EPS Growth Forecast

Scores

Smart Score5
AI Score34.4
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis